Glutamate Receptor Links Aβ-Prion Complex with Fyn, Synaptic Damage
New research connects extracellular Aβ to intracellular kinases that mediate its toxicity.
6397 RESULTS
Sort By:
New research connects extracellular Aβ to intracellular kinases that mediate its toxicity.
Older people improved memory and attention after playing a challenging video game, supporting the idea that multitasking could have benefits for cognition.
New imaging data suggests degeneration of the fornix could help identify seniors on the verge of cognitive decline.
A new study supports the idea that non-motor symptoms of Parkinson's disease may aid earlier diagnosis.
Amyloid fibrils seeded by Alzheimer’s brain extracts indicate that Aβ forms specific strains in different individuals.
Cerebrospinal Fluid Tau Climbs in Aβ Mouse Models Coverage Denial For Amyloid Scans Riles Alzheimer’s Community Pooled GWAS Reveals New Alzheimer’s Genes and Pathways Are Subtle Memory Concerns a Sign of Future Dementia? Clinical Trials Roundup: Four Hits
Experimental α7 Agonist Meets Cognitive and Clinical Endpoints New Assays for Aβ Oligomers in CSF Claim Femtogram Sensitivity Q&A With Roche’s CNS Leader Luca Santarelli When Is a C9ORF72 Repeat Expansion Not a C9ORF72 Repeat Expansion? Wave of Ne
Madrid: ICAD Conference Draws to a Close Madrid: BACE Found to Have Big Job in Wrapping Motoneurons Madrid: Why Do People Drop Out of Trials? Madrid: Stressed Brain—SNP Carriers Can Have Cake and Eat It Madrid: BACE News Roundup, Part 1 Madrid: BACE News
Philadelphia: All Eyes on PIB Imaging—Is It Coming Along? Philadelphia: All Is Not Well with the Statin Story Philadelphia: Can a Shrinking Brain Be Good for You? Philadelphia: Dementia Types Just Won’t Fit into Little Boxes Philadelphia: Diagnosis Light—
Stockholm: Visualizing Amyloid Biggest Draw at Imaging Symposium, Consensus Sought on Validation Stockholm: Chlamydia Triggers Amyloid Plaques in Mice Stockholm: Aph-1 and Pen-2: New Names in the Presenilin Debate Complete the Complex? Stockholm: Clusteri
Washington: Alzhemed Non-story Yields Spotlight to Phase 2 Treatments Washington: Shaking Up AD Treatment with Ketone Bodies Washington: Site-to-Site Differences Delay Result of Alzhemed Trial Washington: γ-secretase Inhibitor Survived Phase 2, Moving to
Chicago: Studies Probe Diminishing Placebo Decline, Part 1 Chicago: Studies Probe Diminishing Placebo Decline, Part 2 Chicago: ICAD Offered Mix Bag of Setbacks and Hopeful News Chicago: Trial Design Bedevils Search for New AD Drugs, Part 1 Chicago: The Ph
Vienna: New Genes, Anyone? ICAD Saves Best for Last Vienna: In Genetics, Bigger Is Better—Data Sharing Nets Three New Hits Vienna: Can a D-Peptide Turn Tiger Into Pussycat? Vienna: New Shoot Among Ashes of Drug Trials Vienna: New Tack to See Amyloid Oligo
Honolulu: FDA Approval in Sight for 18F Amyloid Tracer Florbetapir? Honolulu: Tomm40 Reported to Track With Brain Atrophy, Cognition Honolulu: TrialMatch Launched as AD Is Becoming “Desktop” Disease Honolulu: The Missing Link? Tau Mediates Aβ Toxicity at
Paris: Renamed ARIA, Vasogenic Edema Common to Anti-Amyloid Therapy Paris: Semagacestat Autopsy and Other News of Trial Tribulations Paris: More Trial News, Mixed at Best Paris: President and All, French Science Takes the Stage Paris: Beyond Genomics, Fre